Pathogen.cl
BioSampleModel
2022-11-24
ENA-FIRST-PUBLIC
2022-11-24
ENA-LAST-UPDATE
SAMN31793357
External Id
pda|valenciatibb@wisc.edu
INSDC center alias
pda|valenciatibb@wisc.edu
INSDC center name
2022-11-24T01:42:44Z
INSDC first public
2022-11-24T01:42:44Z
INSDC last update
public
INSDC status
Biological replicate 2
Replicate
SRS15846683
SRA accession
sars_cov_2_omicron_BA5_stock_lot060822_0800_rep02
Submitter Id
NCBI
broker name
BIOQUAL
collected_by
2022-05
collection_date
not provided
culture_collection
Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), isolate hCoV-19/USA/COR-22-063113/2022 was isolated from a human in May 2022, in Tennessee, USA. NR-58620 lot 70053504 was produced by infecting Cercopithecus aethiops kidney epithelial cells expressing transmembrane protease, serine 2 and human angiotensin- converting enzyme 2 (Vero E6-TMPRSS2-T2A-ACE2) (VTA; BEI Resources NR-54970) with the deposited material and incubating in Eagle's Minimum Essential Medium (ATCC® 30-2003TM) supplemented with 2% fetal bovine serum (ATCC® 30-2020TM) for 4 days at 37°C with 5% CO2. The cells and supernatant were spin-clarified at 1500 × g for 10 minutes at 4°C.
description
USA: Tennessee
geo_loc_name
Homo sapiens
host
COVID-19
host_disease
hCoV-19/USA/COR-22-063113/2022
isolate
Severe acute respiratory syndrome coronavirus 2
http://purl.obolibrary.org/obo/NCBITaxon_2697049
organism
Omicron Lineage BA.5
strain
SARS-CoV-2 Omicron BA.5 Stock Lot# 060822-0800 Rep02
title